Kavousi-Gharbi S, Jalli R, Rasekhi-Kazerouni A, Habibagahi Z, Marashi SM. Discernment scheme for paraquat poisoning: A five-year experience in Shiraz, Iran. World J Exp Med 2017; 7(1): 31-39 [PMID: 28261553 DOI: 10.5493/wjem.v7.i1.31]
Corresponding Author of This Article
Sayed Mahdi Marashi, Assistant Professor of Forensic Medicine and Clinical Toxicology, Trauma Research Center, Emergency Room, Division of Medical Toxicology, Hazrat Ali-Asghar (p) Hospital, Shiraz University of Medical Sciences, Zand St., Shiraz 7143918796, Fars Province, Iran. marashi@sums.ac.ir
Research Domain of This Article
Toxicology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Exp Med. Feb 20, 2017; 7(1): 31-39 Published online Feb 20, 2017. doi: 10.5493/wjem.v7.i1.31
Table 1 Baseline demographics of the subjects, 2010-2015
Variable
Total = 104
Gender
Male (%)
69 (66.3)
Female (%)
35 (33.7)
Duration of hospitalization
1-6 d (%)
61 (58.7)
7-13 d (%)
29 (27.9)
More than 14 d (%)
14 (13.5)
Mean (d)
6.73 ± 5.73
Time interval (d)
1-27
Cause of poisoning
Occupational exposure (%)
4 (3.8)
Suicidal (%)
97 (93.3)
Accidental (%)
3 (2.9)
Habitat
Rural (%)
80 (76.9)
Urban (%)
24 (23.1)
Type of poisoning
Ingestion (%)
101 (97.1)
Injection (%)
3 (2.9)
Outcome
Recovery (%)
59 (56.7)
Death due to complications (%)
45 (43.3)
Table 2 Chest radiographic findings of the 45 survivors and non-survivors among paraquat poisoned patients
Radiographic findings
Time interval of radiographic study (d)
No. of patients (percent in the survivors/non-survivors groups)
Non-survivors (n = 18)
Pneumothorax (%)
2-5
2 (11.1)
Pneumomediastinum/emphysema (%)
1-2
2 (11.1)
ARDS (%)
1-10
4 (22.2)
Lung fibrosis (%)
4-14
10 (55.6)
Survivors (n = 27)
Pneumothorax (%)
1-5
2 (7.4)
Lung fibrosis (%)
4-32
4 (14.8)
Normal (%)
1-8
21 (77.8)
Table 3 The cutoff point for the amount of poison consumption and patients’ death
Variable
Area under the ROC (the minimum positive predictive value of 90%)
Cutoff point
Positive predictive value
Negative predictive value
Sensitivity
Specificity
Amount of consumed poison
0.945 (0.87-1.0)
22.5
93.3
98.3
93.3
98.3
Table 4 Cutoff point for the levels of serum creatinine, blood urea nitrogen, aspartate aminotransferase and alanine transaminase on the third day in relation with patients’ death considering the minimum positive predictive value of 90%
Laboratory variables in the third day of admission
Area under the ROC (the minimum positive predictive value of 90%)
Cutoff point
Positive predictive value
Negative predictive value
Sensitivity
Specificity
Serum creatinine
0.90 (0.83-0.97)
1.95
90.9
70.8
90.9
70.8
BUN
0.80 (0.69-0.91)
25
95.4
66.7
95.5
66.7
AST
0.85 (0.58-1.000)
24.5
100
66.78
100
72.7
ALT
0.79 (0.57-1.000)
12
93.3
10.34
88.9
9.1
Citation: Kavousi-Gharbi S, Jalli R, Rasekhi-Kazerouni A, Habibagahi Z, Marashi SM. Discernment scheme for paraquat poisoning: A five-year experience in Shiraz, Iran. World J Exp Med 2017; 7(1): 31-39